Purchase of shares by directors, company secretary and directors of a major subsidiary, award of matching shares LIFE HEALTHCARE GROUP HOLDINGS LIMITED (Incorporated in the Republic of South Africa) (Registration number: 2003/002733/06) ISIN: ZAE000145892 Share Code: LHC (“Life Healthcare” or “the Company”) PURCHASE OF SHARES BY DIRECTORS AND THE COMPANY SECRETARY AND BY DIRECTORS OF A MAJOR SUBSIDIARY AND AWARD OF MATCHING SHARES IN TERMS OF THE LIFE HEALTHCARE 2014 LONG TERM INCENTIVE PLAN (“LTIP”) In compliance with the JSE Limited Listings Requirements, the following information is disclosed: Director : André Meyer Company : Life Healthcare Group Holdings Limited Nature of transaction : The group chief executive officer has been allotted the right to 36 936 matched shares and purchased 21 793 Life Healthcare shares on-market in terms of the LTIP (these shares are restricted for two years and cannot be traded until vesting of the matched shares occurs). Date of transaction : 24 January 2017 Number of securities : 58 729 Class of securities : Ordinary shares Purchase price : R35.0473 Highest price : R35.06 Lowest price : R34.75 Total value of transaction : R2 058 292.88 (of this value, R763 785.81 was paid by the director and R1 294 507.07 paid by the Company) Nature of interest : Direct Beneficial Clearance obtained : Approval for the allocation and clearance to transact has been given Director : Petrus Phillippus van der Westhuizen Company : Life Healthcare Group Holdings Limited Nature of transaction : The group chief financial officer has been allotted the right to 12 509 matched shares and purchased 7 381 Life Healthcare shares on-market in terms of the LTIP (these shares are restricted for two years and cannot be traded until vesting of the matched shares occurs). Date of transaction : 24 January 2017 Number of securities : 19 890 Class of securities : Ordinary shares Purchase price : R35.0473 Highest price : R35.06 Lowest price : R34.75 Total value of transaction : R697 090.80 (of this value, R258 684.12 was paid by the director and R438 406.68 paid by the Company) Nature of interest : Direct Beneficial Clearance obtained : Approval for the allocation and clearance to transact has been given Director : Christoffel Lourens Welthagen Bekker Company : Life Healthcare Group (Proprietary) Limited a major subsidiary of the Company Nature of transaction : The chief operating officer – SA has been allotted the right to 11 765 matched shares and purchased 6 941 Life Healthcare shares on-market in terms of the LTIP (these shares are restricted for two years and cannot be traded until vesting of the matched shares occurs). Date of transaction : 24 January 2017 Number of securities : 18 706 Class of securities : Ordinary shares Purchase price : R35.0473 Highest price : R35.06 Lowest price : R34.75 Total value of transaction : R655 594.79 (of this value, R243 263.31 was paid by the director and R412 331.48 paid by the Company) Nature of interest : Direct Beneficial Clearance obtained : Approval for the allocation and clearance to transact has been given Director : Kurt Aston Wylie Company : Life Healthcare Group (Proprietary) Limited a major subsidiary of the Company Nature of transaction : The business operating executive-SA has been allotted the right to 3 884 matched shares and purchased 2 291 Life Healthcare shares on-market in terms of the LTIP (these shares are restricted for two years and cannot be traded until vesting of the matched shares occurs). Date of transaction : 24 January 2017 Number of securities : 6 175 Class of securities : Ordinary shares Purchase price : R35.0473 Highest price : R35.06 Lowest price : R34.75 Total value of transaction : R216 417.08 (of this value, R80 293.36 was paid by the director and R136 123.71 paid by the Company) Nature of interest : Direct Beneficial Clearance obtained : Approval for the allocation and clearance to transact has been given Director : Pieter Francois Theron Company : Life Healthcare Group (Proprietary) Limited a major subsidiary of the Company Nature of transaction : The chief financial officer-SA has been allotted the right to 6 241 matched shares and purchased 3 682 Life Healthcare shares on-market in terms of the LTIP (these shares are restricted for two years and cannot be traded until vesting of the matched shares occurs). Date of transaction : 24 January 2017 Number of securities : 9 923 Class of securities : Ordinary shares Purchase price : R35.0473 Highest price : R35.06 Lowest price : R34.75 Total value of transaction : R347 774.36 (of this value, R129 044.16 was paid by the director and R218 730.20 paid by the Company) Nature of interest : Direct Beneficial Clearance obtained : Approval for the allocation and clearance to transact has been given Company Secretary : Fazila Patel Company : Life Healthcare Group Holdings Limited Nature of transaction : The company secretary has been allotted the right to 7 605 matched shares and purchased 4 487 Life Healthcare shares on-market in terms of the LTIP (these shares are restricted for two years and cannot be traded until vesting of the matched shares occurs). Date of transaction : 24 January 2017 Number of securities : 12 092 Class of securities : Ordinary shares Purchase price : R35.0473 Highest price : R35.06 Lowest price : R34.75 Total value of transaction : R423 791.95 (of this value, R157 257.24 was paid by the company secretary and R266 534.72 was paid by the Company) Nature of interest : Direct Beneficial Clearance obtained : Approval for the allocation and clearance to transact has been given Illovo 27 January 2016 Sponsor RAND MERCHANT BANK (A division of FirstRand Bank Limited) Date: 27/01/2017 08:12:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.